Here, an increased STAT4 expression correlates with better recurrence-free survival, whereas downregulation of STAT4 in HCC showed more aggressive tumors, enhanced cell proliferation, and worse clinical outcomes [135,136]. The gene discussed is STAT4; the disease is hepatocellular carcinoma.